A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results.
Rouëssé, Jacques
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. [electronic resource] - International journal of radiation oncology, biology, physics Mar 2006 - 1072-80 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0360-3016
10.1016/j.ijrobp.2005.10.011 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Confidence Intervals
Cyclophosphamide--administration & dosage
Disease-Free Survival
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Mitoxantrone--administration & dosage
Neoplasm Recurrence, Local--epidemiology
Neoplasms, Second Primary--classification
Radiotherapy, Adjuvant
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. [electronic resource] - International journal of radiation oncology, biology, physics Mar 2006 - 1072-80 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0360-3016
10.1016/j.ijrobp.2005.10.011 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Confidence Intervals
Cyclophosphamide--administration & dosage
Disease-Free Survival
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Mitoxantrone--administration & dosage
Neoplasm Recurrence, Local--epidemiology
Neoplasms, Second Primary--classification
Radiotherapy, Adjuvant